Accessibility Menu
Fuse Medical logo

Fuse Medical(OTC) FZMD

Market Cap$1.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-98%
5 Year-86%
1 Year-78%
1 Month-2%
$0.02
+0%
+0.00Today
Fuse Medical last closing stock price
MetricPriceDate
Last closeUSD 0.022026-07-28
Fuse Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.52%USD 0.022026-07-16
1 month-2.27%USD 0.022026-06-24
3 month-20.37%USD 0.032026-04-21
Year to date-10.42%USD 0.022025-12-29
1 year-78.46%USD 0.102025-07-23
3 year-73.49%USD 0.082023-07-26
5 year-86.25%USD 0.162021-07-28
Since inception-98.46%USD 1.402018-01-02

Fuse Medical Financials at a Glance

Market Cap

$1.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$18.40M

Net Income (TTM)

$3.63M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.22 (Low)

Price

$0.02

Volume

33,095

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.10

Estimated Earnings Date

Nov 14, 2024

FZMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fuse Medical

Fuse Medical, Inc. is a U.S.-based manufacturer and supplier of medical device implants, primarily focusing on orthopedic solutions. Headquartered in Richardson, Texas, the company offers a diverse range of products, including fixation devices, plating systems, and spinal implants.

Products and Services
  • Orthopedic implants for foot, ankle, and joint reconstruction
  • Soft tissue fixation solutions for sports medicine
  • Osteo-biologics and regenerative products, including human allografts
Growth Outlook
  • Q2 2023 revenue increased to $4.997 million, up from $3.984 million in Q1 2023
  • Gross profit margin improved to 69.4% in Q2 2023, indicating operational efficiency
  • Strong demand for orthopedic products supports future revenue growth
Financial Highlights
  • Trailing twelve-month (TTM) revenue of $19.4 million, reflecting a solid market presence
  • Net income of $307,588 in Q2 2023, a significant turnaround from Q1 2023
  • Current ratio of 1.88, indicating good short-term financial health
Fuse Medical, Inc. operates in the medical devices industry, focusing on orthopedic implants and solutions. The company has shown promising growth, particularly in the second quarter of 2023, with a notable increase in revenue and improved gross profit margins. The diverse product portfolio, which includes both orthopedic and regenerative solutions, positions the company well within the healthcare sector. Recent financial performance indicates a positive trend, with a return to profitability in Q2 2023 after a challenging start to the year. The current ratio suggests that the company is well-equipped to meet its short-term obligations, further enhancing its appeal to potential investors.
AI Generated • Jul 30, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

20

CEO

Christopher C. Reeg

Website

www.fusemedical.com

Headquarters

Farmers Branch, TX 75244, US

FZMD Financials

Key Financial Metrics (TTM)

Gross Margin

71.95%

Operating Margin

4.25%

Net Income Margin

1.52%

Return on Equity

2.05%

Return on Capital

4.10%

Return on Assets

1.06%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

73.90M

Volume

33.09K

Avg. Volume

5.04K

Financials (TTM)

Gross Profit

$11.95M

Operating Income

-$240.25K

EBITDA

$3.93M

Operating Cash Flow

-$404.33K

Capital Expenditure

$522.18K

Free Cash Flow

$18.64K

Cash & ST Invst.

$253.38K

Total Debt

$2.22M

Fuse Medical Performance Analysis

Fuse Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 18,644,784-8.7%
20232023-12-31USD 16,115,483-13.6%
20242024-12-31USD 10,726,177-33.4%
20252025-12-31USD 9,020,912-15.9%
Fuse Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-2.8%
Q42022-12-317.7%
Q12023-03-31-18.5%
Q22023-06-3025.4%
Fuse Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.04N/A
20232023-12-31USD 0.02-52.8%
20242024-12-31USD 0.01-64.9%
20252025-12-31USD 0.00-72.7%
Fuse Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-3097.8%
Q42022-12-3148300.0%
Q12023-03-31-106.6%
Q22023-06-30221.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$5.00M

+7.0%

Gross Profit

$3.47M

+17.8%

Gross Margin

69.42%

N/A

Market Cap

$1.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$51.25K

N/A

Employees

31

N/A

Net Income

$307.59K

+429.6%

EBITDA

$401.57K

+592.1%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Total Cash

$253.38K

-58.0%

Total Debt

$2.22M

-14.3%

Accounts Receivable

$3.43M

+15.8%

Inventory

$9.03M

-3.5%

Long Term Debt

$0.00

N/A

Short Term Debt

$2.22M

-14.3%

Return on Assets

1.06%

N/A

Return on Invested Capital

5.15%

N/A

Free Cash Flow

-$99.20K

+59.7%

Operating Cash Flow

-$99.20K

-361.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KOSKMetawells Oil & Gas Inc.
$0.00-29.64%
VYCOVycor Medical, Inc.
$0.07+0.00%
SRNESorrento Therapeutics, Inc.
$0.00+0.00%
RMSLREMSleep Holdings, Inc.
$0.00-9.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About FZMD

What is the current price of Fuse Medical?

Fuse Medical is trading at $0.02 per share.

What is the 52-week range for Fuse Medical?

Over the past 52 weeks, Fuse Medical has traded between $0.02 and $0.10.

How much debt does Fuse Medical have?

As of the most recent reporting period, Fuse Medical reported total debt of $2.62M.

How much cash does Fuse Medical have on hand?

Fuse Medical reported $339.72K in cash and cash equivalents in its most recent financial results.

What is Fuse Medical’s dividend yield?

Fuse Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services